The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

NCT06707532 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure, Acute
Myopathy; Drugs
Heart Arrhythmia
Succinylcholine Sensitivity
Muscle Relaxation
General Anesthetic Drug Adverse Reaction
Projection

Interventions

DRUG: Propofol
DRUG: Rocuronium

Sponsor

4th Military Clinical Hospital with Polyclinic, Poland